- Home
- AGX vs HUMA Comparison
AGX vs HUMA Comparison
Compare AGX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGX
- HUMA
- Stock Information
- Founded
- AGX 1961
- HUMA 2004
- Country
- AGX United States
- HUMA United States
- Employees
- AGX N/A
- HUMA N/A
- Industry
- AGX Engineering & Construction
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- AGX Consumer Discretionary
- HUMA Health Care
- Exchange
- AGX Nasdaq
- HUMA Nasdaq
- Market Cap
- AGX 1.6B
- HUMA 629.0M
- IPO Year
- AGX N/A
- HUMA N/A
- Fundamental
- Price
- AGX $129.05
- HUMA $4.86
- Analyst Decision
- AGX Strong Buy
- HUMA Strong Buy
- Analyst Count
- AGX 2
- HUMA 7
- Target Price
- AGX $77.50
- HUMA $11.00
- AVG Volume (30 Days)
- AGX 302.1K
- HUMA 3.3M
- Earning Date
- AGX 12-04-2024
- HUMA 11-07-2024
- Dividend Yield
- AGX 1.16%
- HUMA N/A
- EPS Growth
- AGX 20.22
- HUMA N/A
- EPS
- AGX 3.19
- HUMA N/A
- Revenue
- AGX $713,006,000.00
- HUMA N/A
- Revenue This Year
- AGX $35.03
- HUMA N/A
- Revenue Next Year
- AGX $11.83
- HUMA $3,831.37
- P/E Ratio
- AGX $40.40
- HUMA N/A
- Revenue Growth
- AGX 48.03
- HUMA N/A
- 52 Week Low
- AGX $39.74
- HUMA $1.96
- 52 Week High
- AGX $135.66
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- AGX 85.32
- HUMA 37.63
- Support Level
- AGX $108.90
- HUMA $5.57
- Resistance Level
- AGX $116.56
- HUMA $5.81
- Average True Range (ATR)
- AGX 4.74
- HUMA 0.49
- MACD
- AGX 1.69
- HUMA 0.01
- Stochastic Oscillator
- AGX 82.07
- HUMA 19.12
About AGX Argan Inc.
Argan Inc is a United States-base construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derive majority revenue.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.